Similar articles for PMID: 28801876

Year	Number of Results
1994	1
1999	1
2001	1
2005	1
2007	3
2008	1
2009	4
2010	4
2012	3
2013	2
2014	4
2015	5
2016	9
2017	14
2018	9
2019	14
2020	17
2021	9
2022	7
2023	7
2024	1

1

Tumor DNA: an emerging biomarker in head and neck cancer.

Bellairs JA, Hasina R, Agrawal N. Bellairs JA, et al. Cancer Metastasis Rev. 2017 Sep;36(3):515-523. doi: 10.1007/s10555-017-9685-x. Cancer Metastasis Rev. 2017. PMID: 28801876 Free PMC article. Review.

2

Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.

Huang X, Duijf PHG, Sriram S, Perera G, Vasani S, Kenny L, Leo P, Punyadeera C. Huang X, et al. J Biomed Sci. 2023 Aug 9;30(1):65. doi: 10.1186/s12929-023-00953-z. J Biomed Sci. 2023. PMID: 37559138 Free PMC article. Review.

3

The role of tumor DNA as a diagnostic tool for head and neck squamous cell carcinoma.

Chan JYK, Zhen G, Agrawal N. Chan JYK, et al. Semin Cancer Biol. 2019 Apr;55:1-7. doi: 10.1016/j.semcancer.2018.07.008. Epub 2018 Aug 3. Semin Cancer Biol. 2019. PMID: 30082187 Review.

4

Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.

van Ginkel JH, de Leng WW, de Bree R, van Es RJ, Willems SM. van Ginkel JH, et al. Oncotarget. 2016 Sep 20;7(38):61575-61586. doi: 10.18632/oncotarget.11196. Oncotarget. 2016. PMID: 27528217 Free PMC article.

5

Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).

Economopoulou P, Kotsantis I, Kyrodimos E, Lianidou ES, Psyrri A. Economopoulou P, et al. Oral Oncol. 2017 Nov;74:83-89. doi: 10.1016/j.oraloncology.2017.09.012. Epub 2017 Oct 2. Oral Oncol. 2017. PMID: 29103757 Review.

6

Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin.

Califano J, Westra WH, Koch W, Meininger G, Reed A, Yip L, Boyle JO, Lonardo F, Sidransky D. Califano J, et al. J Natl Cancer Inst. 1999 Apr 7;91(7):599-604. doi: 10.1093/jnci/91.7.599. J Natl Cancer Inst. 1999. PMID: 10203278

7

Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.

Payne K, Spruce R, Beggs A, Sharma N, Kong A, Martin T, Parmar S, Praveen P, Nankivell P, Mehanna H. Payne K, et al. Head Neck. 2018 Jul;40(7):1598-1604. doi: 10.1002/hed.25140. Epub 2018 Mar 15. Head Neck. 2018. PMID: 29542214 Review.

8

Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.

Sepiashvili L, Hui A, Ignatchenko V, Shi W, Su S, Xu W, Huang SH, O'Sullivan B, Waldron J, Irish JC, Perez-Ordonez B, Liu FF, Kislinger T. Sepiashvili L, et al. Mol Cell Proteomics. 2012 Nov;11(11):1404-15. doi: 10.1074/mcp.M112.020933. Epub 2012 Aug 23. Mol Cell Proteomics. 2012. PMID: 22918226 Free PMC article.

9

DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.

Hass HG, Schmidt A, Nehls O, Kaiser S. Hass HG, et al. Oral Oncol. 2008 Jan;44(1):78-85. doi: 10.1016/j.oraloncology.2006.12.013. Epub 2007 Mar 9. Oral Oncol. 2008. PMID: 17350326

10

Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.

Mishra V, Singh A, Chen X, Rosenberg AJ, Pearson AT, Zhavoronkov A, Savage PA, Lingen MW, Agrawal N, Izumchenko E. Mishra V, et al. Br J Cancer. 2022 Feb;126(3):361-370. doi: 10.1038/s41416-021-01626-0. Epub 2021 Dec 7. Br J Cancer. 2022. PMID: 34876674 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year